Bottom line
PHSRX vs SCHLX: the short answer
PHSRX (Putnam Global Health Care Fund) and SCHLX (DWS Health and Wellness Fund) are both mutual funds.
SCHLX is cheaper at 1.06% vs 1.29% — a difference of $23 a year per $10,000 invested.
Updated Nov 19, 2026
PHSRX vs SCHLX side by side
| PHSRX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.29% | 1.06% |
| Annual cost per $10k | $129 | $106 |
| 10-yr cost on $10k (prospectus) | $1,556 | $1,294 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +1.0% | — |
| 5-yr return (annualized) | +7.5% | — |
| 10-yr return (annualized) | +7.2% | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $1.5B | $231.8M |
| Number of holdings | 115 | 65 |
| Portfolio turnover | 67% | 2% |
| Returns as of | Dec 31, 2024 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of PHSRX's top 25 holdings also appear in SCHLX's top 25.
| Holding | PHSRX | SCHLX |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 13.85% |
| Johnson & Johnson | 8.46% | 6.19% |
| UnitedHealth Group, Inc. | 6.93% | 5.73% |
| AbbVie, Inc. | 6.05% | 4.90% |
| Merck & Co., Inc. | 4.88% | 4.85% |
| AstraZeneca plc | 4.67% | 3.80% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.46% |
| Intuitive Surgical, Inc. | 4.04% | 2.69% |
| Roche Holding AG | 2.79% | 1.24% |
| Gilead Sciences, Inc. | 2.63% | 2.78% |
| McKesson Corp. | 2.14% | 2.05% |
| Cardinal Health, Inc. | 2.12% | 1.34% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 2.45% |
| Boston Scientific Corp. | 1.80% | 2.10% |
| Bristol-Myers Squibb Co. | 1.75% | 1.50% |
Source: SEC Form N-PORT
PHSRX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between PHSRX and SCHLX?
PHSRX (Putnam Global Health Care Fund) and SCHLX (DWS Health and Wellness Fund) are both mutual funds. SCHLX is cheaper at 1.06% vs 1.29% — a difference of $23 a year per $10,000 invested.
Which is cheaper, PHSRX or SCHLX?
SCHLX has the lower expense ratio (1.06%).
Should I own both PHSRX and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.